Cantitate/Preț
Produs

Incentives for Research, Development, and Innovation in Pharmaceuticals: Series economia de la salud y gestion sanitaria

Editat de Walter A. Garcia-Fontes
en Limba Engleză Paperback – 12 ian 2012
Incentives for innovation are particularly relevant in the pharmaceutical industry where not all social needs provide equally profitable opportunities and where most OECD countries try to implement different measures that promote research in these less profitable areas. This book describes how incentives can be provided to deal with less profitable activities when no clear markets exist for the innovations. The book discusses alternative mechanisms to substitute for inexistent markets, situations where traditional instruments have proven totally insufficient, and the clear mismatch between the size of the markets being targeted and the incentives being provided. Patents become an ineffective way to incentivise R&D when the appropriability is low; this book provides alternative ideas such as allowing for a period of data exclusivity to firms that develop new drugs.
Citește tot Restrânge

Preț: 35220 lei

Preț vechi: 37073 lei
-5% Nou

Puncte Express: 528

Preț estimativ în valută:
6740 7090$ 5594£

Carte tipărită la comandă

Livrare economică 16-30 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9788493806217
ISBN-10: 8493806218
Pagini: 108
Ilustrații: IX, 96 p.
Dimensiuni: 170 x 240 x 6 mm
Greutate: 0.19 kg
Ediția:2011
Editura: Springer
Colecția Springer Healthcare
Seria Series economia de la salud y gestion sanitaria

Locul publicării:Madrid, Spain

Public țintă

Professional/practitioner

Cuprins

Introduction.- Incentives for innovation: a survey.- Incentives for innovation: neglected diseases.- When patents are not enough: supplementary incentives for pharmaceutical innovation.- The Contribution of the United States, Europe and Japan in Discovering New Drugs: 1982 2003.- The use of pay for performance for drugs: can it improve incentives for innovation?.- Drug Price Regulation: Recent Trends and Downstream Neglected Issues.

Notă biografică

Walter Garcia-Fontes is an associate professor at the Department of Economics and Business of Universitat Pompeu Fabra. His research interests are in Industrial Organization, firm innovation, technological change and applied econometrics. He has published his work in leading international field journals. He has coordinated various projects in the European Commission Framework Programmes studying the European chemical industry and the organizational changes related to new industrial relations.

Textul de pe ultima copertă

Incentives for innovation are particularly relevant in the pharmaceutical
industry where not all social needs provide equally profitable
opportunities and where most OECD countries try to implement diffe -
rent measures that promote research in these less profitable areas. The
lack of incentives for innovation is especially dramatic when we take
into account diseases affecting mostly low-income countries, and also
diseases affecting small groups of patients.
How can incentives be provided to deal with these less profitable acti -
vities when no clear markets exist for the innovations being introduced?
Some of the contributions of this book go into discussing alternative
mechanisms to substitute for these inexistent markets, and
situations where traditional instruments such as public procurement or
direct subsidies have proven totally insufficient. Also, this book discusses
the clear mismatch between the size of the markets being targeted and
the incentives being provided.

Caracteristici

In-depth discussion of neglected health economics issues Includes up to date analysis of new data Written by a collection of the leading minds in the field Ground breaking ideas to enhance research and development in the pharmaceutical industry